Alcon Stocks Fall 4% After Lens Implant Sales Slip and Guidance Narrows
U.S. competition pushed implantables down 2%, and Alcon trimmed the top of its 2026 core EPS growth range.
U.S. competition pushed implantables down 2%, and Alcon trimmed the top of its 2026 core EPS growth range.
What's Your Reaction?
